JLUpub
metadata only
Recombinant CCL17 Shifts Microglial Phenotype and Protects Neurons from Oxygen-Glucose Deprivation/Reoxygenation (OGD/R) Injury
Ischemic stroke is a leading cause of death and disability worldwide, characterized by complex neuroinflammatory processes. Microglia serve as the innate immune cells within the central nervous system and are central mediators of neuroinflammatory responses. We investigated whether recombinant CCL17
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A PTM Regulatory Enzyme Co expression Code Defines Microglial Functional Heterogeneity in Cerebral Ischemia Reperfusion Injury#172226
- Transcriptional regulation of disease-relevant microglial activation programs#485089
- Transcriptional regulation of disease-relevant microglial activation programs#226036
- Ginsenoside Rg1 Attenuates Neuroinflammation in Parkinson’s Disease Models via Concomitant Modulation of Canonical and Noncanonical Wnt Pathways in Microglial M1/M2 Polarization#440504
- Targeting microglial C1q alleviates blood-brain barrier disruption in the thalamus after cortical infarction.#251102
Record · ID 988098
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive